Dog Atopic Dermatitis ASIT Outcomes

Allergen-specific immunotherapy offers long-term disease modification for dogs with atopic dermatitis, reducing itch and skin inflammation beyond the period of active treatment.

Key Facts

Canine atopic dermatitis is a chronic inflammatory skin disease driven by hypersensitivity to environmental allergens
Intradermal or serological allergy testing identifies the allergens relevant to an individual dog
ASIT involves regular injections or sublingual drops of allergen extracts to desensitise the immune response
Response rates of approximately 50 to 70 percent are reported across studies
ASIT is the only treatment that modifies the underlying disease mechanism rather than controlling symptoms
Treatment response typically requires six to twelve months before full benefits are apparent

Welfare Considerations

Canine atopic dermatitis causes chronic and severe pruritus that significantly impairs welfare through constant scratching, skin damage, secondary infections, and sleep disruption. Symptomatic treatments provide control but require lifelong administration and carry cumulative side effect risks. ASIT offers the prospect of meaningful long-term improvement in the underlying immune dysregulation. For dogs that respond, reductions in itch and skin inflammation are sustained and may allow reduction in symptomatic medication. The commitment required from owners is significant but justified by the welfare benefit of genuine disease modification.

What You Can Do

Discuss ASIT with a veterinary dermatologist if your dog has moderate to severe atopic dermatitis
Ensure allergen testing is performed to guide ASIT formulation for your individual dog
Be patient with ASIT: benefits accrue over months and initial results may be modest
Maintain concurrent symptom control while waiting for ASIT to take effect
Support veterinary dermatology research into improved allergen identification and ASIT efficacy